Insurance Underwriting & Risk Coverage · Advertiser / Brand
Humana
US health insurer focused on Medicare and integrated care.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Humana Inc.
- Entity type
- COMPANY
- Founded
- 1961
- Headquarters
- 500 West Main Street, Louisville, Kentucky 40202
- Company size
- >5,000
- Market cluster / sector
- Insurance Underwriting & Risk Coverage
- Market role
- Advertiser / Brand
- Ticker
- HUM
- Official website
- humana.com
What Humana does
Humana operates a payer-plus-care-delivery model. It underwrites and administers health insurance coverage, collects recurring premium revenue, receives government reimbursements for Medicare-related plans, and adds downstream value through integrated pharmacy and care services under CenterWell. The company creates value by bundling coverage, provider access, prescription fulfilment and supplemental benefits into products designed for seniors, retirees and other insured populations, while using scale and care coordination to manage medical cost ratios.
Category differentiation
Humana is a managed-care and healthcare services company, not an adtech, martech or media platform. It should not be conflated with product-level technology categories assigned in the raw product extraction.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Humana Inc. is a US healthcare company that sells health insurance products and operates integrated care and pharmacy services. Its core offerings include Medicare Advantage plans, standalone Part D prescription drug plans, group Medicare products for retiree populations, supplemental dental, vision and hearing cover, and CenterWell Pharmacy. The company serves individual members, retirees, employers, brokers and patients, with a strong concentration in senior healthcare and Medicare-related programmes. Humana generates revenue primarily from recurring insurance premiums and government reimbursements tied to Medicare and other public programmes, supplemented by member cost sharing and healthcare service revenue from pharmacy and care delivery. Its commercial model combines payer economics with vertically integrated service delivery intended to manage medical costs, improve retention and deepen member lifetime value.
Company news briefing
Briefing updated:
Humana has reaffirmed its full-year 2026 financial guidance, projecting diluted GAAP EPS of at least $6.52 and non-GAAP Adjusted EPS of at least $9.00. The company is maintaining affordable Medicare Advantage plans and expanding specialized care options for 2027 while withholding commentary on upcoming Star Ratings until official publication. Concurrently, Humana was recognised in Adweek’s 2026 Media Plan of the Year awards alongside Spark Foundry for developing an AI-driven system within the Microsoft Bing ecosystem to boost Medicare enrolments.
Business model & monetisation
Humana monetises through recurring health insurance premiums, Medicare Advantage and Part D reimbursements from government programmes, member deductibles and co-payments, and plan-specific pricing tiers based on coverage scope and geography. Additional revenue comes from pharmacy fulfilment and related healthcare services integrated into the insurance ecosystem. Commercially, this is a mix of subscription-like premium income and service-based healthcare revenue rather than advertising or SaaS licensing.
- Health insurance premiums
- Recurring member premiums
- Government reimbursements
- Programme-based reimbursement for Medicare products
- Member cost sharing
- Deductibles, co-payments and related fees
- Pharmacy services
- Prescription fulfilment and related service revenue
- Care delivery services
- Healthcare service revenue via integrated delivery operations
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Humana
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Humana's competitive landscape.
Integrated health benefits, care delivery and healthcare analytics company.
Global insurer focused on benefits, annuities and retirement solutions.
Integrated US pharmacy, insurance, care delivery and retail media company.
Direct-to-consumer insurance distribution and senior healthcare platform.
German statutory pension, health and social insurance administrator.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
8-K Financial Filing Analysis for Humana (2026-10-13)
financials · Recorded impact score: 4.1/5
On October 13, 2026, Humana Inc. announced a new joint venture arrangement with funds managed by HPS Investment Partners, a subsidiary of BlackRock, Inc., to manage and operate its CenterWell Senior Primary Care clinic network. This arrangement replaces CenterWell's existing joint venture with Welsh, Carson, Anderson & Stowe (WCAS), with BlackRock acquiring WCAS's equity stake under modified terms. Notably, the new JV eliminates the previous put option held by WCAS, resulting in an expected significant reduction in balance sheet liabilities and a lower overall cost of capital. Concurrently, Humana reaffirmed its FY 2026 Adjusted EPS guidance of at least $9.00.
- BlackRock subsidiary HPS Investment Partners acquired WCAS's equity stake in CenterWell Senior Primary Care clinics under a restructured joint venture eliminating previous put option liabilities.
- CenterWell secures the option to purchase clinics starting in 2028, with BlackRock holding exit rights via a sale process by end-2033 if clinics remain unacquired.
8-K Financial Filing Analysis for Humana (2026-10-09)
financials · Recorded impact score: 4.5/5
Humana Inc. announced that it has exceeded its goal of Top Quartile results for the 2027 Medicare Advantage (MA) Star Ratings (Bonus Year 2028), based on final data released by the Centers for Medicare and Medicaid Services (CMS) on October 8, 2026. Top Quartile performance is defined as Stars revenue per member per month (PMPM) at least 10% above the peer group median. While anticipating that a portion of the 2028 bonus outperformance will be one-time in nature, Humana expects to utilize the resulting financial benefit for one-time investments and capital returns to shareholders. Concurrently, the company reaffirmed its full-year 2026 Adjusted EPS guidance of at least $9.00 and announced a virtual investor update scheduled for December 10, 2026.
- Exceeded the Top Quartile target for 2027 CMS Medicare Advantage Star Ratings (Bonus Year 2028), defined as Stars revenue PMPM 10% above the peer group median.
- Reaffirmed full-year 2026 Adjusted EPS guidance of at least $9.00 per share.
Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027
Recorded impact score: 2/5
Press Release | 10/01/2026 Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027
8-K Financial Filing Analysis for Humana (2026-09-01)
financials · Recorded impact score: 3.4/5
On September 1, 2026, Humana Inc. filed a Form 8-K announcing that senior management will reaffirm the company's full-year 2026 financial guidance during upcoming investor and analyst conferences throughout September. Humana continues to project full-year 2026 diluted GAAP EPS of at least $6.52 and non-GAAP Adjusted EPS of at least $9.00, maintaining the outlook originally issued on July 29, 2026. Furthermore, the company clarified that it will withhold commentary regarding the 2027 Medicare Advantage (MA) Star Ratings (Bonus Year 2028) until final data is officially published by the Centers for Medicare and Medicaid Services (CMS) in October.
- Humana reaffirmed its full-year 2026 financial outlook, maintaining targets for diluted GAAP EPS of at least $6.52 and Adjusted EPS of at least $9.00.
- The guidance reconciliation reflects net adjustments of $2.48 per share, including put/call valuations ($1.47), value creation initiatives ($1.27), intangible amortization ($0.30), impairments ($0.17), and tax impacts ($(0.73)).
Explore company relationships
Questions about Humana
What is Humana?
Humana is a US healthcare company that provides health insurance, Medicare-related plans, pharmacy services and care delivery.
Who uses Humana?
Humana serves Medicare-eligible individuals, retirees, employers, brokers, members seeking supplemental cover and patients using pharmacy services.
How does Humana make money?
Humana makes money from insurance premiums, Medicare and other government reimbursements, member cost sharing, and revenue from pharmacy and care services.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
13 publicly documented primary sources and citations linked across the market graph.
Continue your research on Humana
Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Daily intelligent monitoring · Verified primary sources.
Unlock full intelligence profile, ownership & live market signals